Techcyte

Choosing a digital pathology platform is one decision.
Choosing the infrastructure behind it is quite another.

As slide volumes grow and workflows become more connected, many labs are facing new questions around scalability, maintenance, data governance, and long-term flexibility.

Join us for an upcoming webinar exploring SaaS vs. on-premise models in digital pathology and the tradeoffs that can shape your lab for years to come.

→ May 21st | 10 am MT

Reserve your spot: https://hubs.ly/Q04gNY0y0

Today we celebrate the cytotechnologists, cytopathologists, and laboratory teams helping drive the future of cytology through digital workflows and innovation.

We’re proud to support the future of cytology through digital pathology and AI-assisted workflows designed to help laboratories adapt, scale, and innovate.

Happy National Cytotechnology Day to the professionals advancing pathology every day.

We’re excited to share a new milestone for Techcyte.

Today, we're happy to announce a $15 million capital raise led by Van Tuyl Companies, with participation from Mayo Clinic and Zoetis.

This investment supports the continued growth of our AI-powered digital pathology platform and reflects increasing demand for scalable, digital solutions in pathology. We’re grateful to our investors, partners, and customers for being part of this journey.

See what this means for what’s ahead for Techcyte! → https://hubs.ly/Q04f1Ldb0